In journals

Anke L. Stuurman, Miriam Levi, Philippe Beutels, Hélène Bricout, Alexandre Descamps, Gaël Dos Santos, Ian McGovern, Ainara Mira-Iglesias, Jos Nauta, Laurence Torcel-Pagnon, and Jorne Biccler. “Investigating confounding in network-based test-negative design influenza vaccine effectiveness studies-Experience from the DRIVE project.” eng. In: Influenza and other respiratory viruses 17.1 (Jan. 2023). Place: England, e13087. issn: 1750-2659 1750-2640.

Apoorva Sharan, Anke L. Stuurman, Shubhashri Jahagirdar, Varalakshmi Elango, Margarita Riera-Montes, Neeraj Kumar Kashyap, Jorne Biccler, Ramesh Poluru, Narendra Kumar Arora, Mathews Mathai, Punam Mang- tani, Hugo Devlieger, Steven Anderson, Barbee Whitaker, Hui-Lee Wong, Allisyn Moran, and Christine Guillard Maure. “Estimating baseline rates of adverse perinatal and neonatal outcomes using a facility-based surveillance approach: A prospective observational study from the WHO Global Vaccine Safety Multi-Country Collaboration on safety in pregnancy.” eng. In: EClinicalMedicine 50 (Aug. 2022). Place: England, p. 101506. issn: 2589-5370.

Jorne Biccler, Kaatje Bollaerts, Pareen Vora, Elodie Sole, Luis Alberto Garcia Rodriguez, Angel Lanas, Ruth E. Langley, and Montse Soriano Gabarró. “Public health impact of low-dose aspirin on colorectal cancer, cardiovascular disease and safety in the UK - Results from microsimulation model.” eng. In: International journal of cardiology. Heart & vasculature 36 (Oct. 2021). Place: Ireland, p. 100851. issn: 2352-9067.

Anke L. Stuurman, Jorne Biccler, Antonio Carmona, Alexandre Descamps, Javier Díez-Domingoo, Cintia Mũnoz Quiles, Hanna Nohynek, Caterina Rizzo, and Margarita Riera-Montes. “Brand-specific influenza vaccine effectiveness estimates during 2019/20 season in Europe - Results from the DRIVE EU study platform.” eng. In: Vaccine 39.29 (June 2021). Place: Netherlands, pp. 3964–3973. issn: 1873-2518 0264-410X.

Anke L. Stuurman, Apoorva Sharan, Shubhashri Jahagirdar, Varalakshmi Elango, Margarita Riera-Montes, Neeraj Kashyap, Jorne Biccler, Ramesh Poluru, Narendra Arora, Matthews Mathai, Punam Mangtani, Hugo De- Vlieger, Steven Anderson, Barbee Whitaker, Hui-Lee Wong, Clare Cutland, and Christine Guillard Maure. “WHO global vaccine safety multi-country collaboration project on safety in pregnancy: Assessing the level of diagnostic certainty using standardized case definitions for perinatal and neonatal outcomes and maternal immunization.” eng. In: Vaccine: X 9 (Dec. 2021). Place: England, p. 100123. issn: 2590-1362.

Jorne Lionel Biccler, Martin Bøgsted, Stefan Van Aelst, and Tim Verdonck. “Outlier robust modeling of survival curves in the presence of potentially time-varying coefficients.” eng. In: Statistical methods in medical research 29.9 (Sept. 2020). Place: England, pp. 2683–2696. issn: 1477-0334 0962-2802.

Lasse H. Jakobsen, Therese M.-L. Andersson, Jorne L. Biccler, Laurids Ø Poulsen, Marianne T. Severinsen, Tarec C. El-Galaly, and Martin Bøgsted. “On estimating the time to statistical cure.” eng. In: BMC medical research methodology 20.1 (Mar. 2020). Place: England, p. 71. issn: 1471- 2288.

Anke L. Stuurman, Kaatje Bollaerts, Maria Alexandridou, Jorne Biccler, Javier D ́ıez Domingo, Hanna Nohynek, Caterina Rizzo, Topi Turunen, and Margarita Riera-Montes. “Vaccine effectiveness against laboratory-confirmed influenza in Europe - Results from the DRIVE network during season 2018/19.” eng. In: Vaccine 38.41 (Sept. 2020). Place: Netherlands, pp. 6455–6463. issn: 1873-2518 0264-410X.

Allison Barraclough, Musa Alzahrani, Marianne Schmidt Ettrup, Mark Bishton, Chris van Vliet, Pedro Farinha, Clare Gould, Simone Birch, Laurie H. Sehn, Vishakha Sovani, Mitchell Steven Ward, Bradley Augustson, Jorne Biccler, Joseph M. Connors, David W. Scott, Maher K. Gandhi, Kerry J. Savage, Tarec El-Galaly, Diego Villa, and Chan Yoon Cheah. “COO and MYC/BCL2 status do not predict outcome among patients with stage I/II DLBCL: a retrospective multicenter study.” eng. In: Blood advances 3.13 (July 2019). Place: United States, pp. 2013–2021. issn: 2473-9537 2473-9529.

Jorne L. Biccler, Kerry J. Savage, Peter D. N. Brown, Judit Jørgensen, Thomas S. Larsen, Christian B. Poulsen, Danny Stoltenberg, Laurie H. Sehn, David W. Scott, Alina S. Gerrie, Lasse H. Jakobsen, Martin Bøgsted, Tarec C. El-Galaly, and Diego Villa. “Risk of death, relapse or progression, and loss of life expectancy at different progression-free survival milestones in primary central nervous system lymphoma.” eng. In: Leukemia & lymphoma 60.10 (Oct. 2019). Place: United States, pp. 2516–2523. issn: 1029-2403 1026-8022.

Jorne Lionel Biccler, Tarec Christoffer El-Galaly, Martin Bøgsted, Judit Jørgensen, Peter de Nully Brown, Christian Bjørn Poulsen, Jørn Starklint, Maja Bech Juul, Jacob Haaber Christensen, Pär Josefsson, Andriette Dessau, and Lasse Hjort Jakobsen. “Clinical prognostic scores are poor predictors of overall survival in various types of malignant lymphomas.” eng. In: Leukemia & lymphoma 60.6 (June 2019). Place: United States, pp. 1580–1583. issn: 1029-2403 1026-8022.

Jorne Lionel Biccler, Ingrid Glimelius, Sandra Eloranta, Knut B. Smeland, Peter de Nully Brown, Lasse Hjort Jakobsen, Henrik Frederiksen, Mats Jerkeman, Alexander Fosså, Therese M. L. Andersson, Harald Holte, Martin Bøgsted, Tarec Christoffer El-Galaly, and Karin E. Smedby. “Relapse Risk and Loss of Lifetime After Modern Combined Modality Treatment of Young Patients With Hodgkin Lymphoma: A Nordic Lymphoma Epidemiology Group Study.” eng. In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 37.9 (Mar. 2019). Place: United States, pp. 703–713. issn: 1527-7755 0732-183X.

Lasse H. Jakobsen, Therese M.-L. Andersson, Jorne L. Biccler, Tarec C. El-Galaly, and Martin Bøgsted. “Estimating the loss of lifetime function using flexible parametric relative survival models.” eng. In: BMC medical research methodology 19.1 (Jan. 2019). Place: England, p. 23. issn: 1471- 2288.

Lasse Hjort Jakobsen, Jorne Lionel Biccler, Peter de Nully Brown, Judit Mészáros Jørgensen, Pär Lars Josefsson, Christian Bjørn Poulsen, Jørn Starklin, Michael Roost Clausen, Per Trøllund Pedersen, Maja Bech Juul, Marianne Tang Severinsen, Martin Bøgsted, and Tarec Christoffer El- Galaly. “No differential overall or relative survival effect of rituximab in male and female patients with diffuse large B-cell lymphoma: a Danish population-based study of 3783 patients.” eng. In: Leukemia & lymphoma 60.11 (Nov. 2019). Place: United States, pp. 2798–2801. issn: 1029-2403 1026-8022.

Michael Asger Andersen, Casper Tabassum Eriksen, Christian Brieghel, Jorne Lionel Biccler, Caspar da Cunha-Bang, Marie Helleberg, and Carsten Utoft Niemann. “Incidence and predictors of infection among patients prior to treatment of chronic lymphocytic leukemia: a Danish nationwide cohort study.” eng. In: Haematologica 103.7 (July 2018). Place: Italy, e300–e303. issn: 1592-8721 0390-6078.

Jorne Biccler, Sandra Eloranta, Peter de Nully Brown, Henrik Frederiksen, Mats Jerkeman, Karin E. Smedby, Martin Bøgsted, and Tarec C. El- Galaly. “Simplicity at the cost of predictive accuracy in diffuse large B-cell lymphoma: a critical assessment of the R-IPI, IPI, and NCCN-IPI.” eng. In: Cancer medicine 7.1 (Jan. 2018). Place: United States, pp. 114–122. issn: 2045-7634. 10.1002/cam4.1271.

Jorne L. Biccler, Sandra Eloranta, Peter de Nully Brown, Henrik Frederiksen, Mats Jerkeman, Judit Jørgensen, Lasse Hjort Jakobsen, Karin E. Smedby, Martin Bøgsted, and Tarec C. El-Galaly. “Optimizing Outcome Prediction in Diffuse Large B-Cell Lymphoma by Use of Machine Learning and Nationwide Lymphoma Registries: A Nordic Lymphoma Group Study.” eng. In: JCO clinical cancer informatics 2 (Dec. 2018). Place: United States, pp. 1–13. issn: 2473-4276.

Jorne Lionel Biccler, Lene Sofie Granfeldt Østgård, Marianne Tang Severinsen, Claus Werenberg Marcher, Peter Møller, Claudia Schöllopf, Lone Smidstrup Friis, Martin Bøgsted, Lasse Hjort Jakobsen, Tarec Christoffer El-Galaly, and Jan Maxwell Nørgaard. “Evolution of relative survival for acute promyelocytic leukemia patients alive at landmark time-points: a population-based study.” eng. In: Leukemia 32.10 (Oct. 2018). Place: Eng- land, pp. 2263–2303. issn: 1476-5551 0887-6924.

Caroline Holm Nørgaard, Nikoline Buus Søgaard,Jorne Lionel Biccler, Laura Pilgaard, Mathias Holmsgaard Eskesen, Thordis Helga Kjartansdottir, Martin Bøgsted, and Tarec Christoffer El-Galaly. “Limited value of routine follow-up visits in chronic lymphocytic leukemia managed initially by watch and wait: A North Denmark population-based study.” eng. In: PloS one 13.12 (2018). Place: United States, e0208180. issn: 1932-6203.